Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
Purpose. To show the long-term results of intravitreal ranibizumab combined with photodynamic therapy (PDT) for the treatment of polypoidal choroidal vasculopathy (PCV). Methods. We analyzed the progress of two patients for 36 and 58 months, respectively. We only used PDT for the treatment in the ar...
Saved in:
Main Authors: | Maribel Fernández, María Gil, Francisco Gomez-Ulla, Pablo Charlón |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/897097 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review
by: Yimin Wang, et al.
Published: (2020-01-01) -
Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
by: Hassan Hamoudi, et al.
Published: (2011-01-01) -
Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-01-01) -
Detection Rate and Diagnostic Value of Optical Coherence Tomography Angiography in the Diagnosis of Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis
by: Yuelin Wang, et al.
Published: (2019-01-01) -
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
by: Burak Erden, et al.
Published: (2019-01-01)